Q1 earnings, FII action, auto sales among 9 factors to keep Dalal… MUMBAI: After clocking gains for four consecutive weeks, benchmark indices gave up… Read More...
Promoter pledge in these 5 cos significantly down in FY23, stocks turn… The pledge of stake by promoters in several companies that are part of the BSE500… Read More...
Adani group will thrive with or without Modi, bets GQG’s Jain Veteran fund manager Rajiv Jain said his GQG Partners LLC holds about $13 billion in… Read More...
Sun Pharma offers to acquire 100% stake in Taro in an all-cash deal Sun Pharmaceutical Industries has proposed acquisition of all the shares of Taro… Read More...
Q4 results, Fed minutes among 7 factors to drive D-Street… MUMBAI: Volatility is likely to be the theme on Dalal Street in the coming week, as… Read More...
Throwback! D-St bulls caught in rollercoaster ride after peaking in… Mumbai: October 19 has in some way been symbolic to Dalal Street traders, as on the… Read More...
Sun Pharma might finally have a prescription for the specialty dream MUMBAI: is increasingly showing signs that it has left behind the stuttering start… Read More...
Brokerages up price targets on rising Sun, some point to clouds Credit Suisse said the valuation of Sun is not factoring in moderation in high… Read More...
Market Movers: Two factors that triggered big spike in Sun Pharma MUMBAI: After Dr Reddy’s Laboratories’ 10 per cent collapse on Wednesday, investors… Read More...